Skip to Main Content

Paper Details

Overcoming Genetically Based Resistance Mechanisms to PD-1 Blockade.
Cancer Discov
82
2020
B2M, CD122, CD4, CD4 T-, CD4 T-cell, CD8, CD8 T cells, Human, Human melanoma cell lines, IFN, IFN receptor, IL2, JAK1, JAK1/2, JAK2, NK, NK cells, NK-cell, PD-1, Toll-like receptor 9, anti-PD-1, antigen, antigen-specific T cells, bempegaldesleukin, deficient, human, human and murine cell lines, melanoma, murine, natural killer
Author NameAffiliation
Katie M CampbellUniversity of California los angeles
Anusha KalbasiUniversity of California los angeles
Jesse M ZaretskyUniversity of California los angeles
Jesse M ZaretskyUniversity of California los angeles
Antoni RibasUniversity of California los angeles
Antoni RibasUniversity of California los angeles
Antoni RibasUniversity of California los angeles
Antoni RibasJonsson Comprehensive Cancer Center
Antoni RibasParker Institute for Cancer Immunotherapy
Antoni RibasUniversity of California los angeles
Antoni RibasUniversity of California los angeles
Antoni RibasUniversity of California los angeles
Antoni RibasJonsson Comprehensive Cancer Center
Antoni RibasParker Institute for Cancer Immunotherapy
  • 1 - 14

Datasets

Release 1.2